PDS Planning Inc Buys Shares of 4,320 CVS Health Corporation (NYSE:CVS)

PDS Planning Inc purchased a new position in shares of CVS Health Corporation (NYSE:CVS - Free Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,320 shares of the pharmacy operator's stock, valued at approximately $293,000.

Other large investors also recently modified their holdings of the company. LaFleur & Godfrey LLC increased its stake in shares of CVS Health by 49.9% in the fourth quarter. LaFleur & Godfrey LLC now owns 4,836 shares of the pharmacy operator's stock valued at $217,000 after buying an additional 1,610 shares during the period. IFP Advisors Inc grew its holdings in CVS Health by 91.3% during the 4th quarter. IFP Advisors Inc now owns 21,413 shares of the pharmacy operator's stock worth $961,000 after acquiring an additional 10,222 shares during the last quarter. New York Life Investment Management LLC increased its position in CVS Health by 0.8% in the 4th quarter. New York Life Investment Management LLC now owns 168,675 shares of the pharmacy operator's stock valued at $7,572,000 after acquiring an additional 1,370 shares during the period. Mn Services Vermogensbeheer B.V. raised its stake in shares of CVS Health by 2.0% during the fourth quarter. Mn Services Vermogensbeheer B.V. now owns 505,900 shares of the pharmacy operator's stock valued at $22,710,000 after acquiring an additional 9,900 shares during the last quarter. Finally, Kovack Advisors Inc. lifted its holdings in shares of CVS Health by 23.4% during the fourth quarter. Kovack Advisors Inc. now owns 10,940 shares of the pharmacy operator's stock worth $491,000 after purchasing an additional 2,078 shares during the period. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Performance

NYSE:CVS opened at $68.50 on Friday. The company has a quick ratio of 0.63, a current ratio of 0.82 and a debt-to-equity ratio of 0.77. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $72.51. The company has a fifty day moving average of $64.86 and a 200-day moving average of $60.79. The firm has a market capitalization of $86.66 billion, a P/E ratio of 16.35, a P/E/G ratio of 0.98 and a beta of 0.56.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.63. The firm had revenue of $94.59 billion during the quarter, compared to the consensus estimate of $93.07 billion. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The business's revenue was up 7.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.31 earnings per share. As a group, sell-side analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the company. Piper Sandler increased their price objective on CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a report on Friday, March 21st. Mizuho upped their price target on CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. UBS Group raised their price objective on CVS Health from $67.00 to $71.00 and gave the stock a "neutral" rating in a research report on Friday, May 2nd. Wall Street Zen raised CVS Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Finally, Barclays set a $79.00 target price on shares of CVS Health and gave the company an "overweight" rating in a research report on Monday, June 2nd. Two investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, CVS Health presently has an average rating of "Moderate Buy" and an average target price of $74.75.

Insider Buying and Selling

In other CVS Health news, Director Guy P. Sansone purchased 1,570 shares of the firm's stock in a transaction on Thursday, June 5th. The stock was acquired at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the purchase, the director now owns 12,007 shares of the company's stock, valued at $764,845.90. This trade represents a 15.04% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 1.22% of the stock is owned by company insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.